Vestcor Inc’s Maravai LifeSciences MRVI Stock Holding History

Vestcor Inc’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-9,927	Closed	-$86K	–	1232
2024 Q1	$86K	Hold	9,927	–	–	﹤0.01%	1123
2023 Q4	$65K	Buy	+9,927	New	+$64.1K	﹤0.01%	1119
2022 Q2	–	Sell	-5,000	Closed	-$176K	–	1427
2022 Q1	$176K	Buy	+5,000	New	+$168K	0.01%	960

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Vestcor Inc's MRVI Position: Q2 2024 in Review

Vestcor Inc sold out of Maravai LifeSciences (MRVI) in Q2 2024, closing a stake of 9,927 shares — an estimated $86K sold.

Vestcor Inc first reported a position in MRVI in Q1 2022 and held it in 3 quarters. The position peaked at $176K in Q1 2022. 206 funds tracked by Wall St. Rank hold MRVI as of Q2 2024.

Vestcor Inc reported no remaining Maravai LifeSciences position as of Q2 2024 after selling out during the quarter.
Vestcor Inc sold 9,927 Maravai LifeSciences shares in Q2 2024, an estimated $86K.
Vestcor Inc first reported a position in Maravai LifeSciences in Q1 2022 and held it in 3 quarters.
Vestcor Inc's Maravai LifeSciences position peaked at $176K in Q1 2022.
206 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2024.

Based on Vestcor Inc's 13F filing for Q2 2024, filed 13 Aug 2024.